Cross Country Healthcare, Inc. (CCRN)

Cross Country Healthcare Stock Forecast

Stock Price Forecast

The 4 analysts that cover Cross Country Healthcare stock have a consensus rating of "Buy" and an average price target of $13.15, which forecasts a 31.04% increase in the stock price over the next year. The lowest target is $9.00 and the highest is $18.61.

Price Target: $13.15 (+31.04%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$9.00	$13.15	$14	$18.61
Change	-10.31%	+31.04%	+39.51%	+85.45%

Analyst Ratings

The average analyst rating for Cross Country Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	1	1	0	0	0	1
Buy	0	0	0	0	0	0
Hold	4	4	3	3	4	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	5	3	3	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Bill Sutherland Benchmark	Benchmark	Hold → Strong Buy Upgrades $14	Hold → Strong Buy	Upgrades	$14	+39.51%	Mar 5, 2026
Michael Piccolo Wedbush	Wedbush	Hold Initiates $11	Hold	Initiates	$11	+9.62%	Feb 3, 2026
A.J. Rice UBS	UBS	Hold Maintains $17 → $9	Hold	Maintains	$17 → $9	-10.31%	Dec 9, 2025
Kevin Steinke Barrington Research	Barrington Research	Hold Maintains $19	Hold	Maintains	$19	+85.45%	Jun 17, 2025
A.J. Rice UBS	UBS	Hold Maintains $19 → $17	Hold	Maintains	$19 → $17	+64.42%	May 13, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

1.03B

Decreased by -1.92%

from 1.05B

Revenue Next Year

1.08B

Increased by 4.35%

from 1.03B

EPS This Year

0.10

from -2.93

EPS Next Year

0.10

Increased by 7.09%

from 0.10

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	1.68B	2.80B	2.02B	1.34B	1.05B	1.03B	1.08B
Revenue Growth	100.46%	67.20%	-27.95%	-33.46%	-21.56%	-1.92%	4.35%
EPS	3.53	4.95	2.05	-0.44	-2.93	0.10	0.10
EPS Growth	-	40.23%	-58.59%	-	-	-	7.09%
Forward PE	-	-	-	-	-	102.79	95.98
No. Analysts	-	-	-	-	-	9	6

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	1.1B	1.2B
Avg	1.0B	1.1B
Low	965.0M	995.7M

Revenue Growth

Revenue Growth	2026	2027
High	6.9%	15.1%
Avg	-1.9%	4.4%
Low	-8.5%	-3.7%

EPS Forecast

EPS	2026	2027
High	0.34	0.21
Avg	0.10	0.10
Low	-0.04	0.02

EPS Growth

EPS Growth	2026	2027
High	-	115.1%
Avg	-	7.1%
Low	-	-79.9%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.